MRC Clinical Trials Unit at UCL to become the UCL Innovative Clinical Trials Unit from April 2026
The Innovative Clinical Trials Unit is committed to fulfilling the mission of smarter studies and global impact, leading to better health.
16 Feb
NeoSep1 Part 1 study shows promising antibiotic options for newborns with suspected sepsis
New results found that off-patent antibiotics fosfomycin and flomoxef were safe in newborn babies with suspected sepsis.
22 Jan
Groundbreaking £50m MRC Centre will overhaul clinical trials for patients
The centre plans to shake up approaches to clinical trial design and delivery by developing pioneering new ways to speed up the process and drive improvements in treatment and recovery.
18 Dec
International collaboration sheds light on how aspirin prevents cancer
A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.
11 Dec
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes